A
ACAD
Acadia Pharmaceuticals Inc
22.56
+0.47+2.13%After Hours: 22.56 0.00 0.00%16:10 04/08 EDT
OPEN/PREV CLOSE22.85/22.09
TODAY RANGE22.39-22.86
VOL1.64M
MARKET CAP3.85B
52 WEEK RANGE13.40-28.35
AVG VOL (3M)1.68M
% TURNOVER0.96%
TURNOVER--
P/E (TTM)9.80
% RANGE2.13%
EPS(TTM)2.301
P/E(FORWARD)51.27
P/B3.130
BVPS7.21
DIVIDEND--
P/S3.586
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.79B
SHARES OUTSTANDING170.49M
NEXT EARNINGS05/05-05/11
FREE FLOAT168.19M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
The Motley Fool·18h ago
Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off
Simply Wall St·23h ago
Will DAYBUE STIX Launch Deepen Acadia Pharmaceuticals' (ACAD) Stake in Rett Syndrome Treatment Narrative
Seeking Alpha·6d ago
Biotech Is Holding Steady In 2026
Seeking Alpha·6d ago
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports
NASDAQ·03/27 15:30
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Simply Wall St·03/27 03:08
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Mixed Share Performance
Benzinga·03/25 19:43
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Seeking Alpha·03/25 15:51
Acadia Pharma upgraded at BofA following stock pullback
TipRanks·03/25 13:50
Arm upgraded, Mondelez downgraded: Wall Street’s top analyst calls
Dow Jones·03/25 12:54
ACADIA Pharmaceuticals Raised to Buy From Neutral by B of A Securities
Same Industry
Name/Symbol
Change%
Price